Detailed information for compound 1049958

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 565.499 | Formula: C24H34Cl2N10O2
  • H donors: 4 H acceptors: 0 LogP: 1.98 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 2
  • SMILES: COc1cc(ccc1N1C(=NC(=NC1(C)C)N)N)c1ccc(c(c1)OC)N1C(=NC(=NC1(C)C)N)N.Cl.Cl
  • InChi: 1S/C24H32N10O2.2ClH/c1-23(2)31-19(25)29-21(27)33(23)15-9-7-13(11-17(15)35-5)14-8-10-16(18(12-14)36-6)34-22(28)30-20(26)32-24(34,3)4;;/h7-12H,1-6H3,(H4,25,27,29,31)(H4,26,28,30,32);2*1H
  • InChiKey: BUYRFXSAKRKWRP-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Entamoeba histolytica hypothetical protein 0.0192 0.0589 1
Entamoeba histolytica hypothetical protein 0.0192 0.0589 1
Brugia malayi AMP-binding enzyme family protein 0.0054 0.0085 0.0085
Mycobacterium ulcerans acyl-CoA synthetase 0.0054 0.0085 1
Mycobacterium tuberculosis Probable oxidoreductase 0.0312 0.1029 1
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0281 0.0914 0.8855
Brugia malayi Serotonin receptor 0.0512 0.1761 0.1761
Trypanosoma cruzi hypothetical protein, conserved 0.0464 0.1588 1
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0043 0.0041 0.5
Mycobacterium ulcerans dihydrolipoamide dehydrogenase, LpdB 0.0043 0.0041 0.1442
Echinococcus granulosus histone acetyltransferase KAT2B 0.0044 0.0048 0.0031
Entamoeba histolytica acyl-CoA synthetase, putative 0.0054 0.0085 0.091
Schistosoma mansoni hypothetical protein 0.0078 0.017 0.0153
Echinococcus granulosus tumor protein p63 0.2175 0.786 0.7857
Leishmania major 4-coumarate:coa ligase-like protein 0.0054 0.0085 0.0279
Trypanosoma cruzi hypothetical protein, conserved 0.0464 0.1588 1
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0312 0.1029 1
Brugia malayi Calcitonin receptor-like protein seb-1 0.0114 0.0302 0.0302
Trichomonas vaginalis bromodomain-containing protein, putative 0.0044 0.0048 0.1556
Mycobacterium tuberculosis Conserved protein 0.0053 0.0081 0.055
Toxoplasma gondii histone lysine acetyltransferase GCN5-B 0.0044 0.0048 0.021
Mycobacterium ulcerans fatty-acid-CoA ligase 0.0054 0.0085 1
Loa Loa (eye worm) hypothetical protein 0.0041 0.0034 0.0017
Trypanosoma brucei hypothetical protein, conserved 0.0464 0.1588 1
Leishmania major 4-coumarate:coa ligase-like protein 0.0054 0.0085 0.0279
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0281 0.0914 0.8855
Echinococcus granulosus thioredoxin glutathione reductase 0.0124 0.034 0.0324
Loa Loa (eye worm) hypothetical protein 0.0041 0.0034 0.0017
Schistosoma mansoni transcription factor LCR-F1 0.0192 0.0589 0.0573
Entamoeba histolytica hypothetical protein 0.0192 0.0589 1
Brugia malayi hypothetical protein 0.0192 0.0589 0.0589
Schistosoma mansoni hypothetical protein 0.0146 0.042 0.0404
Brugia malayi Thioredoxin reductase 0.0123 0.0336 0.0336
Leishmania major hypothetical protein, conserved 0.0464 0.1588 1
Loa Loa (eye worm) hypothetical protein 0.0041 0.0034 0.0017
Trypanosoma cruzi 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative 0.0053 0.0081 0.0257
Loa Loa (eye worm) camk/mapkapk/mapkapk protein kinase 0.2759 1 1
Loa Loa (eye worm) hypothetical protein 0.0041 0.0034 0.0017
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0054 0.0085 0.0584
Plasmodium falciparum glutathione reductase 0.0123 0.0336 1
Mycobacterium ulcerans citrate (pro-3S)-lyase subunit beta 0.0053 0.0081 0.9334
Echinococcus multilocularis thioredoxin glutathione reductase 0.0124 0.034 0.0324
Echinococcus multilocularis dihydrolipoamide dehydrogenase 0.0043 0.0041 0.0025
Mycobacterium tuberculosis Probable citrate (pro-3S)-lyase (beta subunit) CitE (citrase) (citratase) (citritase) (citridesmolase) (citrase aldolase) 0.0053 0.0081 0.055
Mycobacterium leprae PROBABLE NADH DEHYDROGENASE NDH 0.0281 0.0914 0.8784
Schistosoma mansoni gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 0.0151 0.0438 0.0422
Echinococcus multilocularis tumor protein p63 0.2175 0.786 0.7857
Echinococcus granulosus Mitotic checkpoint protein PRCC C terminal 0.0146 0.042 0.0404
Mycobacterium ulcerans long-chain-fatty-acid--CoA ligase 0.0054 0.0085 1
Brugia malayi AMP-binding enzyme family protein 0.0054 0.0085 0.0085
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0123 0.0336 0.3093
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0114 0.0302 0.0285
Echinococcus granulosus citrate lyase subunit beta protein 0.0053 0.0081 0.0064
Brugia malayi Latrophilin receptor protein 2 0.0036 0.0017 0.0017
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0192 0.0589 0.0573
Mycobacterium ulcerans hypothetical protein 0.0054 0.0085 1
Echinococcus granulosus dihydrolipoamide dehydrogenase 0.0043 0.0041 0.0025
Mycobacterium ulcerans dihydrolipoamide dehydrogenase 0.0043 0.0041 0.1442
Trichomonas vaginalis cat eye syndrome critical region protein 2, cscr2, putative 0.0044 0.0048 0.1556
Mycobacterium ulcerans long-chain fatty-acid CoA ligase 0.0054 0.0085 1
Brugia malayi dihydrolipoyl dehydrogenase, mitochondrial precursor, putative 0.0043 0.0041 0.0041
Echinococcus multilocularis gcn5proteinral control of amino acid synthesis 0.0151 0.0438 0.0422
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0312 0.1029 1
Leishmania major 4-coumarate:coa ligase-like protein 0.0054 0.0085 0.0279
Plasmodium falciparum thioredoxin reductase 0.0123 0.0336 1
Loa Loa (eye worm) hypothetical protein 0.0054 0.0085 0.0068
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0281 0.0914 0.8855
Mycobacterium ulcerans hypothetical protein 0.0053 0.0081 0.9334
Brugia malayi acetyltransferase, GNAT family protein 0.0151 0.0438 0.0438
Giardia lamblia NADH oxidase lateral transfer candidate 0.0043 0.0041 1
Echinococcus multilocularis microtubule associated protein 2 0.224 0.8097 0.8094
Mycobacterium tuberculosis Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) 0.0054 0.0085 0.0584
Mycobacterium ulcerans acyl-CoA synthetase 0.0054 0.0085 1
Mycobacterium tuberculosis Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot 0.0043 0.0041 0.0154
Plasmodium vivax dihydrolipoyl dehydrogenase, apicoplast, putative 0.0043 0.0041 0.0241
Echinococcus granulosus histone acetyltransferase KAT2B 0.0146 0.0422 0.0406
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0281 0.0914 0.8855
Schistosoma mansoni cellular tumor antigen P53 0.0318 0.1052 0.1037
Schistosoma mansoni microtubule-associated protein tau 0.224 0.8097 0.8094
Brugia malayi calcium-independent alpha-latrotoxin receptor 2, putative 0.0036 0.0017 0.0017
Trypanosoma cruzi trypanothione reductase, putative 0.0123 0.0336 0.1906
Plasmodium falciparum acyl-CoA synthetase 0.0041 0.0034 0.0002
Echinococcus multilocularis MAP kinase activated protein kinase 2 0.2759 1 1
Loa Loa (eye worm) hypothetical protein 0.0041 0.0034 0.0017
Echinococcus granulosus microtubule associated protein 2 0.224 0.8097 0.8094
Entamoeba histolytica acyl-coA synthetase, putative 0.0054 0.0085 0.091
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.0043 0.0041 1
Leishmania major trypanothione reductase 0.0123 0.0336 0.1906
Brugia malayi glutathione reductase 0.0123 0.0336 0.0336
Schistosoma mansoni dihydrolipoamide dehydrogenase 0.0043 0.0041 0.0025
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0192 0.0589 0.0573
Brugia malayi latrophilin 2 splice variant baaae 0.0078 0.017 0.017
Leishmania major 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative 0.0053 0.0081 0.0257
Trypanosoma cruzi 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative 0.0053 0.0081 0.0257
Loa Loa (eye worm) hypothetical protein 0.0114 0.0302 0.0285
Schistosoma mansoni thyroid hormone receptor 0.0158 0.0463 0.0447
Mycobacterium ulcerans citrate lyase beta subunit, CitE_2 0.0053 0.0081 0.9334
Loa Loa (eye worm) thioredoxin reductase 0.0123 0.0336 0.032
Plasmodium vivax thioredoxin reductase, putative 0.0123 0.0336 1
Plasmodium falciparum dihydrolipoyl dehydrogenase, mitochondrial 0.0043 0.0041 0.0243
Plasmodium vivax glutathione reductase, putative 0.0123 0.0336 1
Entamoeba histolytica acyl-CoA synthetase, putative 0.0054 0.0085 0.091
Echinococcus granulosus MAP kinase activated protein kinase 2 0.2759 1 1
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0114 0.0302 0.0302
Loa Loa (eye worm) hypothetical protein 0.0054 0.0085 0.0068
Mycobacterium tuberculosis Probable reductase 0.0281 0.0914 0.8855
Plasmodium falciparum glutathione reductase 0.0043 0.0041 0.0243
Mycobacterium ulcerans acyl-CoA synthetase 0.0054 0.0085 1
Treponema pallidum NADH oxidase 0.0043 0.0041 0.5
Onchocerca volvulus 0.0318 0.1052 1
Loa Loa (eye worm) glutathione reductase 0.0123 0.0336 0.032
Toxoplasma gondii thioredoxin reductase 0.0123 0.0336 1
Entamoeba histolytica hypothetical protein 0.0192 0.0589 1
Trypanosoma brucei trypanothione reductase 0.0123 0.0336 0.1906
Loa Loa (eye worm) hypothetical protein 0.0078 0.017 0.0153
Schistosoma mansoni serine/threonine protein kinase 0.2759 1 1
Plasmodium vivax dihydrolipoyl dehydrogenase, mitochondrial, putative 0.0043 0.0041 0.0241
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0043 0.0041 0.5
Plasmodium vivax histone acetyltransferase GCN5, putative 0.0044 0.0048 0.0446
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0312 0.1029 1
Trichomonas vaginalis Citrate lyase beta chain, putative 0.0053 0.0081 1
Schistosoma mansoni thyroid hormone receptor 0.0158 0.0463 0.0447
Mycobacterium ulcerans citrate (pro-3S)-lyase subunit beta 0.0053 0.0081 0.9334
Echinococcus multilocularis Mitotic checkpoint protein PRCC, C terminal 0.0146 0.042 0.0404
Mycobacterium ulcerans flavoprotein disulfide reductase 0.0043 0.0041 0.1442
Mycobacterium ulcerans hypothetical protein 0.0053 0.0081 0.9334
Mycobacterium tuberculosis Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) 0.0041 0.0034 0.0081
Echinococcus multilocularis thyroid hormone receptor alpha 0.0158 0.0463 0.0447
Schistosoma mansoni hypothetical protein 0.0192 0.0589 0.0573
Plasmodium falciparum dihydrolipoyl dehydrogenase, apicoplast 0.0043 0.0041 0.0243
Loa Loa (eye worm) hypothetical protein 0.0318 0.1052 0.1037
Brugia malayi AMP-binding enzyme family protein 0.0054 0.0085 0.0085
Loa Loa (eye worm) acetyltransferase 0.0151 0.0438 0.0422
Echinococcus multilocularis citrate lyase subunit beta protein 0.0053 0.0081 0.0064
Mycobacterium ulcerans long-chain-fatty-acid-CoA ligase 0.0054 0.0085 1
Plasmodium falciparum thioredoxin reductase 0.0043 0.0041 0.0243
Toxoplasma gondii histone lysine acetyltransferase GCN5-A 0.0044 0.0048 0.021
Mycobacterium tuberculosis Probable dehydrogenase 0.0281 0.0914 0.8855
Loa Loa (eye worm) hypothetical protein 0.0054 0.0085 0.0068

Activities

Activity type Activity value Assay description Source Reference
Delta MST (functional) = 2.2 day Antitrypanosomal activity was evaluated against Trypanosoma rhodesiense infections in mice,at dose 1.6mg/kg,administered subcutaneously ChEMBL. 4067999
Delta MST (functional) = 3 day Antitrypanosomal activity against Trypanosoma rhodesiense infections in mice, 13 mg/kg administered subcutaneously ChEMBL. 4067999
Delta MST (functional) = 3.2 day Antitrypanosomal activity was evaluated against Trypanosoma rhodesiense infections in mice,at dose 212 mg/kg,administered subcutaneously ChEMBL. 4067999
Delta MST (functional) = 4.9 day Antitrypanosomal activity was evaluated against Trypanosoma rhodesiense infections in mice,at dose 53 mg/kg,administered subcutaneously ChEMBL. 4067999
Delta MST (functional) = 7.2 day Antitrypanosomal activity against Trypanosoma rhodesiense infections in mice, 3.3 mg/kg administered subcutaneously ChEMBL. 4067999
Delta MST (functional) = 8.9 day Anti-trypanosomal activity against Trypanosoma rhodesiense infections in mice, 26 mg/kg administered subcutaneously ChEMBL. 4067999
Delta MST (functional) = 11.2 day Antitrypanosomal activity against Trypanosoma rhodesiense infections in mice, 106 mg/kg administered subcutaneously ChEMBL. 4067999
Delta MST (functional) = 13.5 day Antitrypanosomal activity against Trypanosoma rhodesiense infections in mice, 6.6 mg/kg administered subcutaneously ChEMBL. 4067999
Toxic (functional) = 5 Antitrypanosomal activity against Trypanosoma rhodesiense infections in mice, 424 mg/kg administered subcutaneously ChEMBL. 4067999

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.